1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CMO Peptide Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 APIs and Intermediates
        1.2.3 FDF
    1.3 Market by Application
        1.3.1 Global CMO Peptide Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Commercial
        1.3.3 Academic Research
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CMO Peptide Market Perspective (2017-2028)
    2.2 CMO Peptide Growth Trends by Region
        2.2.1 CMO Peptide Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CMO Peptide Historic Market Size by Region (2017-2022)
        2.2.3 CMO Peptide Forecasted Market Size by Region (2023-2028)
    2.3 CMO Peptide Market Dynamics
        2.3.1 CMO Peptide Industry Trends
        2.3.2 CMO Peptide Market Drivers
        2.3.3 CMO Peptide Market Challenges
        2.3.4 CMO Peptide Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CMO Peptide Players by Revenue
        3.1.1 Global Top CMO Peptide Players by Revenue (2017-2022)
        3.1.2 Global CMO Peptide Revenue Market Share by Players (2017-2022)
    3.2 Global CMO Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CMO Peptide Revenue
    3.4 Global CMO Peptide Market Concentration Ratio
        3.4.1 Global CMO Peptide Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CMO Peptide Revenue in 2021
    3.5 CMO Peptide Key Players Head office and Area Served
    3.6 Key Players CMO Peptide Product Solution and Service
    3.7 Date of Enter into CMO Peptide Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CMO Peptide Breakdown Data by Type
    4.1 Global CMO Peptide Historic Market Size by Type (2017-2022)
    4.2 Global CMO Peptide Forecasted Market Size by Type (2023-2028)
5 CMO Peptide Breakdown Data by Application
    5.1 Global CMO Peptide Historic Market Size by Application (2017-2022)
    5.2 Global CMO Peptide Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CMO Peptide Market Size (2017-2028)
    6.2 North America CMO Peptide Market Size by Country (2017-2022)
    6.3 North America CMO Peptide Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe CMO Peptide Market Size (2017-2028)
    7.2 Europe CMO Peptide Market Size by Country (2017-2022)
    7.3 Europe CMO Peptide Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CMO Peptide Market Size (2017-2028)
    8.2 Asia-Pacific CMO Peptide Market Size by Country (2017-2022)
    8.3 Asia-Pacific CMO Peptide Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America CMO Peptide Market Size (2017-2028)
    9.2 Latin America CMO Peptide Market Size by Country (2017-2022)
    9.3 Latin America CMO Peptide Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CMO Peptide Market Size (2017-2028)
    10.2 Middle East & Africa CMO Peptide Market Size by Country (2017-2022)
    10.3 Middle East & Africa CMO Peptide Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bachem
        11.1.1 Bachem Company Detail
        11.1.2 Bachem Business Overview
        11.1.3 Bachem CMO Peptide Introduction
        11.1.4 Bachem Revenue in CMO Peptide Business (2017-2022)
        11.1.5 Bachem Recent Development
    11.2 PolyPeptide
        11.2.1 PolyPeptide Company Detail
        11.2.2 PolyPeptide Business Overview
        11.2.3 PolyPeptide CMO Peptide Introduction
        11.2.4 PolyPeptide Revenue in CMO Peptide Business (2017-2022)
        11.2.5 PolyPeptide Recent Development
    11.3 USV Peptides
        11.3.1 USV Peptides Company Detail
        11.3.2 USV Peptides Business Overview
        11.3.3 USV Peptides CMO Peptide Introduction
        11.3.4 USV Peptides Revenue in CMO Peptide Business (2017-2022)
        11.3.5 USV Peptides Recent Development
    11.4 Thermofischer
        11.4.1 Thermofischer Company Detail
        11.4.2 Thermofischer Business Overview
        11.4.3 Thermofischer CMO Peptide Introduction
        11.4.4 Thermofischer Revenue in CMO Peptide Business (2017-2022)
        11.4.5 Thermofischer Recent Development
    11.5 Bio Basic
        11.5.1 Bio Basic Company Detail
        11.5.2 Bio Basic Business Overview
        11.5.3 Bio Basic CMO Peptide Introduction
        11.5.4 Bio Basic Revenue in CMO Peptide Business (2017-2022)
        11.5.5 Bio Basic Recent Development
    11.6 JPT
        11.6.1 JPT Company Detail
        11.6.2 JPT Business Overview
        11.6.3 JPT CMO Peptide Introduction
        11.6.4 JPT Revenue in CMO Peptide Business (2017-2022)
        11.6.5 JPT Recent Development
    11.7 Genscript
        11.7.1 Genscript Company Detail
        11.7.2 Genscript Business Overview
        11.7.3 Genscript CMO Peptide Introduction
        11.7.4 Genscript Revenue in CMO Peptide Business (2017-2022)
        11.7.5 Genscript Recent Development
    11.8 Xinbang Pharma
        11.8.1 Xinbang Pharma Company Detail
        11.8.2 Xinbang Pharma Business Overview
        11.8.3 Xinbang Pharma CMO Peptide Introduction
        11.8.4 Xinbang Pharma Revenue in CMO Peptide Business (2017-2022)
        11.8.5 Xinbang Pharma Recent Development
    11.9 ScinoPharm
        11.9.1 ScinoPharm Company Detail
        11.9.2 ScinoPharm Business Overview
        11.9.3 ScinoPharm CMO Peptide Introduction
        11.9.4 ScinoPharm Revenue in CMO Peptide Business (2017-2022)
        11.9.5 ScinoPharm Recent Development
    11.10 AmbioPharm
        11.10.1 AmbioPharm Company Detail
        11.10.2 AmbioPharm Business Overview
        11.10.3 AmbioPharm CMO Peptide Introduction
        11.10.4 AmbioPharm Revenue in CMO Peptide Business (2017-2022)
        11.10.5 AmbioPharm Recent Development
    11.11 SN Biopharm
        11.11.1 SN Biopharm Company Detail
        11.11.2 SN Biopharm Business Overview
        11.11.3 SN Biopharm CMO Peptide Introduction
        11.11.4 SN Biopharm Revenue in CMO Peptide Business (2017-2022)
        11.11.5 SN Biopharm Recent Development
    11.12 CBL
        11.12.1 CBL Company Detail
        11.12.2 CBL Business Overview
        11.12.3 CBL CMO Peptide Introduction
        11.12.4 CBL Revenue in CMO Peptide Business (2017-2022)
        11.12.5 CBL Recent Development
    11.13 Piramal Pharma
        11.13.1 Piramal Pharma Company Detail
        11.13.2 Piramal Pharma Business Overview
        11.13.3 Piramal Pharma CMO Peptide Introduction
        11.13.4 Piramal Pharma Revenue in CMO Peptide Business (2017-2022)
        11.13.5 Piramal Pharma Recent Development
    11.14 CordenPharma
        11.14.1 CordenPharma Company Detail
        11.14.2 CordenPharma Business Overview
        11.14.3 CordenPharma CMO Peptide Introduction
        11.14.4 CordenPharma Revenue in CMO Peptide Business (2017-2022)
        11.14.5 CordenPharma Recent Development
    11.15 CPC Scientific
        11.15.1 CPC Scientific Company Detail
        11.15.2 CPC Scientific Business Overview
        11.15.3 CPC Scientific CMO Peptide Introduction
        11.15.4 CPC Scientific Revenue in CMO Peptide Business (2017-2022)
        11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global CMO Peptide Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of APIs and Intermediates
    Table 3. Key Players of FDF
    Table 4. Global CMO Peptide Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global CMO Peptide Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global CMO Peptide Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global CMO Peptide Market Share by Region (2017-2022)
    Table 8. Global CMO Peptide Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global CMO Peptide Market Share by Region (2023-2028)
    Table 10. CMO Peptide Market Trends
    Table 11. CMO Peptide Market Drivers
    Table 12. CMO Peptide Market Challenges
    Table 13. CMO Peptide Market Restraints
    Table 14. Global CMO Peptide Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global CMO Peptide Market Share by Players (2017-2022)
    Table 16. Global Top CMO Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO Peptide as of 2021)
    Table 17. Ranking of Global Top CMO Peptide Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by CMO Peptide Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players CMO Peptide Product Solution and Service
    Table 21. Date of Enter into CMO Peptide Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global CMO Peptide Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global CMO Peptide Revenue Market Share by Type (2017-2022)
    Table 25. Global CMO Peptide Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global CMO Peptide Revenue Market Share by Type (2023-2028)
    Table 27. Global CMO Peptide Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global CMO Peptide Revenue Market Share by Application (2017-2022)
    Table 29. Global CMO Peptide Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global CMO Peptide Revenue Market Share by Application (2023-2028)
    Table 31. North America CMO Peptide Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America CMO Peptide Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe CMO Peptide Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe CMO Peptide Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific CMO Peptide Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific CMO Peptide Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America CMO Peptide Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America CMO Peptide Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa CMO Peptide Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa CMO Peptide Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Bachem Company Detail
    Table 42. Bachem Business Overview
    Table 43. Bachem CMO Peptide Product
    Table 44. Bachem Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 45. Bachem Recent Development
    Table 46. PolyPeptide Company Detail
    Table 47. PolyPeptide Business Overview
    Table 48. PolyPeptide CMO Peptide Product
    Table 49. PolyPeptide Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 50. PolyPeptide Recent Development
    Table 51. USV Peptides Company Detail
    Table 52. USV Peptides Business Overview
    Table 53. USV Peptides CMO Peptide Product
    Table 54. USV Peptides Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 55. USV Peptides Recent Development
    Table 56. Thermofischer Company Detail
    Table 57. Thermofischer Business Overview
    Table 58. Thermofischer CMO Peptide Product
    Table 59. Thermofischer Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 60. Thermofischer Recent Development
    Table 61. Bio Basic Company Detail
    Table 62. Bio Basic Business Overview
    Table 63. Bio Basic CMO Peptide Product
    Table 64. Bio Basic Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 65. Bio Basic Recent Development
    Table 66. JPT Company Detail
    Table 67. JPT Business Overview
    Table 68. JPT CMO Peptide Product
    Table 69. JPT Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 70. JPT Recent Development
    Table 71. Genscript Company Detail
    Table 72. Genscript Business Overview
    Table 73. Genscript CMO Peptide Product
    Table 74. Genscript Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 75. Genscript Recent Development
    Table 76. Xinbang Pharma Company Detail
    Table 77. Xinbang Pharma Business Overview
    Table 78. Xinbang Pharma CMO Peptide Product
    Table 79. Xinbang Pharma Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 80. Xinbang Pharma Recent Development
    Table 81. ScinoPharm Company Detail
    Table 82. ScinoPharm Business Overview
    Table 83. ScinoPharm CMO Peptide Product
    Table 84. ScinoPharm Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 85. ScinoPharm Recent Development
    Table 86. AmbioPharm Company Detail
    Table 87. AmbioPharm Business Overview
    Table 88. AmbioPharm CMO Peptide Product
    Table 89. AmbioPharm Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 90. AmbioPharm Recent Development
    Table 91. SN Biopharm Company Detail
    Table 92. SN Biopharm Business Overview
    Table 93. SN Biopharm CMO PeptideProduct
    Table 94. SN Biopharm Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 95. SN Biopharm Recent Development
    Table 96. CBL Company Detail
    Table 97. CBL Business Overview
    Table 98. CBL CMO PeptideProduct
    Table 99. CBL Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 100. CBL Recent Development
    Table 101. Piramal Pharma Company Detail
    Table 102. Piramal Pharma Business Overview
    Table 103. Piramal Pharma CMO PeptideProduct
    Table 104. Piramal Pharma Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 105. Piramal Pharma Recent Development
    Table 106. CordenPharma Company Detail
    Table 107. CordenPharma Business Overview
    Table 108. CordenPharma CMO PeptideProduct
    Table 109. CordenPharma Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 110. CordenPharma Recent Development
    Table 111. CPC Scientific Company Detail
    Table 112. CPC Scientific Business Overview
    Table 113. CPC Scientific CMO PeptideProduct
    Table 114. CPC Scientific Revenue in CMO Peptide Business (2017-2022) & (US$ Million)
    Table 115. CPC Scientific Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CMO Peptide Market Share by Type: 2021 VS 2028
    Figure 2. APIs and Intermediates Features
    Figure 3. FDF Features
    Figure 4. Global CMO Peptide Market Share by Application in 2021 & 2028
    Figure 5. Commercial Case Studies
    Figure 6. Academic Research Case Studies
    Figure 7. Other Case Studies
    Figure 8. CMO Peptide Report Years Considered
    Figure 9. Global CMO Peptide Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global CMO Peptide Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global CMO Peptide Market Share by Region: 2021 VS 2028
    Figure 12. Global CMO Peptide Market Share by Players in 2021
    Figure 13. Global Top CMO Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO Peptide as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by CMO Peptide Revenue in 2021
    Figure 15. North America CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America CMO Peptide Market Share by Country (2017-2028)
    Figure 17. United States CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe CMO Peptide Market Share by Country (2017-2028)
    Figure 21. Germany CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific CMO Peptide Market Share by Region (2017-2028)
    Figure 29. China CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America CMO Peptide Market Share by Country (2017-2028)
    Figure 37. Mexico CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa CMO Peptide Market Share by Country (2017-2028)
    Figure 41. Turkey CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia CMO Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Bachem Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 44. PolyPeptide Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 45. USV Peptides Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 46. Thermofischer Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 47. Bio Basic Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 48. JPT Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 49. Genscript Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 50. Xinbang Pharma Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 51. ScinoPharm Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 52. AmbioPharm Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 53. SN Biopharm Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 54. CBL Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 55. Piramal Pharma Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 56. CordenPharma Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 57. CPC Scientific Revenue Growth Rate in CMO Peptide Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed